Erasca, Inc.’s Post

We are pleased to announce that we have initiated our SEACRAFT-2 pivotal Phase 3 trial evaluating naporafenib plus trametinib in patients with NRAS-mutant melanoma! Click the link below for more details about this exciting update. #Erasca #Erasecancer https://lnkd.in/gs2btYgz

We are #hiring! Join us in our ambitious goal to #erasecancer. Contact Shinji Fujimori or Guevara Rowand for more information.

Happy Administrative Professionals Day to our incredible admin team who keep our offices running seamlessly to ensure the success of our teams! Thank you for your hard work, your positivity, and your unwavering commitment to excellence.  Your dedication and support do not go unnoticed. We are grateful for all that you do! Elisabeth Lopez, J. Alonzo C., Jen Roberts #AdministrativeProfessionalsDay #Thankyou #Erasca #Erasecancer

As we reflect at the end of #WomensHistoryMonth, we want to take a moment to celebrate the tremendous women in our Finance and Accounting department here at #Erasca. From meticulously managing our financial resources to ensuring compliance and accuracy, their dedication and expertise are instrumental in driving our vision forward. We are truly fortunate to have them as integral members of our team. Take a look at what motivated them to join our mission to #erasecancer. 

We’re #hiring. Contact Guevara Rowand, Roxana (Serbanescu) Picard or Amy (Grekowicz) Parker, MPH for more information and join us in our ambitious goal to #erasecancer!

This week for #WomensHistoryMonth we would like to highlight another one of our amazing Erasca women, Roxana (Serbanescu) Picard, Director, Clinical Operations. By collaborating closely with clinical site partners, vendor colleagues, and functional leaders, Roxana plays a crucial role in driving the timely success of our clinical trials. We truly appreciate Roxana’s dedication and contributions to Erasca! Learn more about what she does and how her work impacts our mission. #Erasca #Erasecancer 

As #WomensHistoryMonth continues, we would like to shine a light on Susan Zhao, Vice President, Statistical Programming and Data Management! Throughout Susan’s career she has had the opportunity to work on many positive phase III oncology clinical trials and gained FDA approval for many effective cancer drugs. Her work is very important and critical to the success of our ongoing clinical trials at Erasca. Susan has been fortunate to have worked with many female role models who have had a positive impact on her career. See what Susan is proud of and what she has to say about two significant women in her career! #Erasca #Erasecancer 

Happy Women's History Month! Throughout March, we're excited to shine a spotlight on a few of our incredible women at Erasca who are essential to what we do! To start, we’d like to introduce you to Valerie Rojas, MS, PMP, RAC, Associate Director, Regulatory Affairs. Take a look at the important role Valerie plays in furthering our mission and who in her career has been an influential role model! 

On Employee Appreciation Day, we extend our heartfelt gratitude to the talented and dedicated individuals driving our mission to erase cancer! We are extremely grateful for each one of our Erascals. Thank you for your hard work, passion and commitment every day! #Erasca #EmployeeAppreciationDay #Erasecancer #Thankyou 

We have exciting news this week! Erasca has been granted FDA Fast Track designation for our pan-RAF inhibitor Naporafenib in patients with advanced NRAS-mutated melanoma. Find more details in the link below: #Erasca #Erasecancer https://lnkd.in/dDgVzNqU